Medical Advisory Board:
Daniel Sessler, MD, Medical Advisor
Dr. Sessler attended medical school at Columbia University, and subsequently completed pediatric and anesthesia residencies at the University of California, Los Angeles. Having served as a Professor at the University of California in San Francisco and as Vice-dean for Research at the University of Louisville, he is now the Michael Cudahy Professor and Chair of the Department of Outcomes Research at the Cleveland Clinic. Dr. Sessler is Director of the Outcomes Research Consortium: the Consortium is the world’s largest clinical anesthesia research group and publishes a full paper every 4 days. Dr. Sessler has published a book on therapeutic hypothermia and more than 630 full research papers including a dozen in the New England Journal of Medicine and Lancet. His papers have been cited more than 25,000 times, and more than 60 were accompanied by editorials. He has been a principal or co-investigator on grants exceeding $40 million, half from peer-reviewed sources. Dr. Sessler is an editor for Anesthesiology and serves as a reviewer for more than 50 journals. He has given invited lectures at more than 340 institutions. He serves as a director for the Anesthesia Quality Institute (AQI) and the Foundation for Anesthesia Education and Research (FAER). Among Dr. Sessler’s awards is a Fulbright Fellowship and the American Society of Anesthesiologists Excellence in Research prize.
Andrea Kurz, MD, Medical Advisor
Dr. Kurz attended the University of Vienna School of Medicine, and completed an anesthesia residency and fellowship at the University of Vienna. She was then a research fellow in the Outcomes Research Consortium Laboratory in San Francisco and an Associate Professor in the Department of Anesthesia and Critical Care at the University of California in San Francisco . Subsequently, she was Professor of Anesthesia in the Department of Anesthesia and General Intensive Care at the University of Vienna. Dr. Kurz was an Associate Professor of Anesthesia at Washington University in St. Louis for four years where she directed the Department of Anesthesia Clinical Research Center. She subsequently chaired the Department of Anesthesiology at the University of Bern for four years, a period of extraordinary research productivity for the Department. Dr. Kurz is now Vice-chair of the Department of Outcomes Research and Chair of the Department of General Anesthesiology at the Cleveland Clinic.
Bahman Guyuron, MD, FACS, Medical Advisor, Board of Directors
Dr. Guyuron has developed an international reputation for his innovations in rhinoplasty and facial aesthetic surgery, publishing over 175 articles in peer-reviewed journals, 43 book chapters, and two textbooks. Previously, he served as President of the American Association of Plastic Surgeons, Director of the American Board of Plastic Surgery, Chairman of the Department of Plastic Surgery at Case Western Reserve University/University Hospitals Case Medical Center, Director of the Section of Craniofacial Surgery at the Cleveland Clinic Foundation, and Chief of the Division of Plastic Surgery at the former Mt. Sinai Medical Center. Dr. Guyuron is a graduate of Tehran University Medical School. He completed a residency in general surgery at Boston University and a residency in plastic surgery at The Cleveland Clinic Foundation – as well as a fellowship in craniofacial surgery at Toronto University Hospital for Sick Children.
Business Advisors and Board Members:
Brian Patrick, Co-Founder & Board of Directors
Mr. Patrick is a healthcare innovation entrepreneur and a business knowledge leader in the therapeutic temperature management, bioheat transfer, and advanced thermoregulation sectors. He brings significant, hands-on founder and executive experience to Mercury. Having founded the predecessor company to Mercury Biomed (CoolCore), and having co-founded Mercury (both spun out of UT Austin), Brian has extensive experience connecting the academic and business sectors to commercialize life sciences research.
As a Director of Business Development and Entrepreneur in Residence at Baylor College of Medicine, Brian supports the identification, evaluation, formation, and growth of new BCM companies. He focuses on early-stage development of medical innovations with disruptive, commercial potential and fostering relationships between inventors, investors, and strategic partners. Working closely with the Baylor Licensing Group, Baylor, and the BCM Office of Research, his mission is to actualize BCM’s vision to improve health through science and innovation.
Mr. Patrick holds an M.B.A. from the University of St. Thomas (TX) and a B.A. in Political Science from the University of Houston.
James Kuras, Board of Directors
Mr. Kuras has over 25 years of broad and extensive experience leading business operations, corporate governance, financing, quality control and product development functions in lifescience and medical device companies. Prior to Mercury Biomed, Mr. Kuras was the Chief Operating Officer and co-founder of AxioMed Spine Corp (ASC), raising $70 million in venture funding. ASC was founded in 2001 based on the intellectual property involving unique designs for cervical and lumbar artificial spinal disc implants. Additionally, he has led strategic business and operational plans for the US, European, and Pacific Rim markets, also executing product development, clinical assessments (class 2b, ll & lll) and commercialization for the US and OUS markets. Mr. Kuras holds 14 medical device patents, and earned his BSAS degree in Electrical Engineering Technology from Youngstown State University.
Terry Ozan, Board of Directors
Mr. Ozan serves on the board of directors of TFS Financial (Third Federal Savings) with assets of $12 Billion (Nasdaq). He is also a board member of State Industrial Products, Cohesant, Inc. and Innovative Medical Equipment. He recently retired from the Board of Capgemini (Paris Stock Exchange), an $11 billion worldwide provider of consulting, technology services and outsourcing. Prior to 2003, Mr. Ozan served as Chief Executive Officer of North American operations and was a member of the Capgemini Global Executive Committee. Before the formation of Capgemini in 2000 (as the combination of E&Y Consulting and Capgemini), he was the Chief Executive Officer of worldwide consulting services at Ernst & Young and served on various global boards and executive committees. In his nearly 30 year career at Ernst & Young, Mr. Ozan also directed many different U.S. business units.
Mr. Ozan holds a BS in Electrical Engineering and a Masters in Operations Research from Cornell University.